Fabiana Napolitano

University of Naples Federico II

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (4)

Ariella Hanker

assistant professor

University of Texas Southwestern Medical Center

UNITED STATES

View details

Siyuan Zhang

Associate Professor

University of Texas Southwestern Medical Center

UNITED STATES

View details

CARMINE DE ANGELIS

Assistant Professor

University of Naples Federico II

ITALY

View details

Luigi Formisano

Università Federico II

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Fabiana Napolitano

Research Interests

Explore related searches

Contact this professor

Articles (10)

Censoring in trials testing immunotherapy in advanced cancers: a systematic review and a meta-research study

A bedside-to-bench translational analysis of NF1 alterations and CDK4/6 inhibitor resistance in hormone receptor-positive metastatic breast cancer

Selective degradation of FGFR1/2 overcomes antiestrogen resistance in ER+ breast cancer with FGFR1/2 alterations

AP1-mediated reprogramming of EGFR expression triggers resistance to BLU-667 and LOXO-292 in RET-rearranged tumors

ESR1 Y537S and D538G Mutations Drive Resistance to CDK4/6 Inhibitors in Estrogen Receptor–Positive Breast Cancer

Early assessment of IL8 and PD1+ Treg predicts response and guides treatment monitoring in cemiplimab-treated cutaneous squamous cell carcinoma

EGFR and HER2 hyper-activation mediates resistance to endocrine therapy and CDK4/6 inhibitors in ER+ breast cancer

Mapping cellular interactions from spatially resolved transcriptomics data.

Blinded independent central review versus local investigator assessment of PFS in RCTs of immunotherapy in advanced cancers: A systematic review and meta-analysis

Combined inhibition of CDK4/6 and AKT is highly effective against the luminal androgen receptor (LAR) subtype of triple negative breast cancer

Collaborators (4)

Ariella Hanker

Siyuan Zhang

CARMINE DE ANGELIS

Luigi Formisano

Make your next move.